CN111019881B - A cell adapted to a high osmotic pressure, high ammonium ion, high lactic acid growth environment - Google Patents
A cell adapted to a high osmotic pressure, high ammonium ion, high lactic acid growth environment Download PDFInfo
- Publication number
- CN111019881B CN111019881B CN201911149208.9A CN201911149208A CN111019881B CN 111019881 B CN111019881 B CN 111019881B CN 201911149208 A CN201911149208 A CN 201911149208A CN 111019881 B CN111019881 B CN 111019881B
- Authority
- CN
- China
- Prior art keywords
- cells
- cell
- cho
- osmotic pressure
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明属于细胞领域,具体涉及一种适应高渗透压、高铵离子、高乳酸生长环境的细胞。The invention belongs to the field of cells, and in particular relates to a cell adapted to a high osmotic pressure, high ammonium ion and high lactic acid growth environment.
背景技术Background technique
随着基因组学,分子生物学以及现代医学的不断发展,生物医药产业也逐步展现出其特有的优势并在近十年来在国内取得了快速的发展,其中重组蛋白药物,特别是抗体类药物发展最为迅速,国内已经有一大批企业以及研究机构从事抗肿瘤,心血管,免疫疾病方向的抗体开发研究工作,多个抗体药物已经上市。With the continuous development of genomics, molecular biology and modern medicine, the biopharmaceutical industry has gradually shown its unique advantages and has achieved rapid development in China in the past ten years. Among them, recombinant protein drugs, especially antibody drugs, have developed Most rapidly, a large number of domestic companies and research institutions have been engaged in antibody development and research in the direction of anti-tumor, cardiovascular, and immune diseases, and a number of antibody drugs have been launched.
目前抗体类蛋白大都使用CHO细胞(Chinese hamster ovary cell)作为生产用细胞株,因为CHO细胞相较于其它细胞具有不可比拟的优势,例如表达的抗体与其天然结构相似,其分离纯化方法便捷,也具有更好的生物安全性等等。作为抗体表达的宿主细胞,细胞的生长特性,表达量对生物药的成本和质量起到了决定性的作用,目前细胞表达抗体的水平还较低,工艺和生产成本都较高,从而导致了生物药价格居高不下。一方面是生产设备和耗材成本高,另一方面则是细胞生产水平较低。在生物发酵生产抗体类蛋白过程中,随着细胞产物和代谢物的增加,发酵液中的环境趋于极端,比如渗透压增加,铵离子、乳酸浓度增高,这都会导致细胞的死亡和活率下降,最终影响到细胞的产率降低。At present, CHO cells (Chinese hamster ovary cell) are mostly used as production cell lines for antibody proteins, because CHO cells have incomparable advantages over other cells. For example, the expressed antibodies are similar to their natural structures, and their separation and purification methods are convenient. Has better biosecurity and more. As host cells for antibody expression, the growth characteristics and expression levels of cells play a decisive role in the cost and quality of biological drugs. At present, the level of antibody expression in cells is still low, and the process and production costs are high, resulting in biological drugs. Prices remain high. On the one hand, the cost of production equipment and consumables is high, and on the other hand, the level of cell production is low. In the process of biological fermentation to produce antibody-like proteins, with the increase of cell products and metabolites, the environment in the fermentation broth tends to be extreme, such as the increase of osmotic pressure, the increase of ammonium ion and lactic acid concentration, which will lead to cell death and viability. decrease, ultimately affecting the yield of cells.
目前已有的CHO细胞株一般只能在低渗透压(小于350mOsm/Kg)和(或)低氨离子浓度(小于7.5mM)和(或)低乳酸(小于2.5g/L)的培养环境中生长。培养基提供适当的生长环境供细胞生长,在此培养的过程中,使用者通过检测手段,获得细胞生长、生物质材料(蛋白,DNA,细胞等)信息。细胞株的自身代谢和生物材料的分泌,导致培养基提供的适当环境被破坏,很多时候导致高渗透压(大于350mOsm/Kg)和(或)高氨离子浓度的培养环境(大于7.5mM)和(或)高乳酸(大于2.5g/L)的培养环境中。在这种培养环境中,细胞株无法正常生长,也不能生产生物材料。The existing CHO cell lines generally can only be cultured in a culture environment with low osmotic pressure (less than 350mOsm/Kg) and/or low ammonia ion concentration (less than 7.5mM) and/or low lactate (less than 2.5g/L). grow. The culture medium provides an appropriate growth environment for the cells to grow. During the cultivation process, the user obtains information on cell growth and biomass materials (protein, DNA, cells, etc.) through detection means. The cell line's own metabolism and secretion of biological materials lead to the destruction of the appropriate environment provided by the medium, which in many cases results in a culture environment with high osmotic pressure (greater than 350mOsm/Kg) and/or high ammonia ion concentration (greater than 7.5mM) and (or) in a culture environment with high lactic acid (greater than 2.5g/L). In this culture environment, cell lines cannot grow normally and cannot produce biological material.
发明内容SUMMARY OF THE INVENTION
本发明的目的提供一种适应高渗透压、高铵离子、高乳酸生长环境的中国仓鼠卵巢上皮细胞CHO-K1-OAL,该中国仓鼠卵巢上皮细胞CHO-K1-OAL于2019年8月19日保藏于中国微生物菌种保藏管理委员会普通微生物中心(CGMCC),地址:北京市朝阳区北辰西路1号院3号,保藏编号为:CGMCC No.18322。The purpose of the present invention is to provide a Chinese hamster ovary epithelial cell CHO-K1-OAL adapted to a high osmotic pressure, high ammonium ion, and high lactic acid growth environment. It is preserved in the General Microbiology Center (CGMCC) of the China Microorganism Culture Collection Management Committee, address: No. 3, No. 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number is: CGMCC No.18322.
鉴于目前已有的CHO细胞株一般只能在低渗透压(小于350mOsm/Kg)和(或)低氨离子浓度(小于7.5mM)和(或)低乳酸(小于2.5g/L)的培养环境中生长,本发明将运用合理的方式,驯化获得能够在高渗透压和(或)高氨离子浓度和(或)高乳酸的培养环境中生长的CHO细胞株,从而避免随着发酵过程的进行而导致细胞产量的降低,从而实现了本发明的目的。In view of the fact that the existing CHO cell lines are generally only in low osmotic pressure (less than 350mOsm/Kg) and (or) low ammonia ion concentration (less than 7.5mM) and (or) low lactic acid (less than 2.5g/L) culture environment The present invention will use a reasonable method to domesticate and obtain the CHO cell strain that can grow in the culture environment of high osmotic pressure and (or) high ammonia ion concentration and (or) high lactic acid, so as to avoid the progress of the fermentation process. As a result, the yield of cells is reduced, thereby achieving the object of the present invention.
本发明的第二个目的是提供所述的中国仓鼠卵巢上皮细胞CHO-K1-OAL作为生产菌株在生产抗体类蛋白产品中的应用。The second object of the present invention is to provide the application of the Chinese hamster ovary epithelial cell CHO-K1-OAL as a production strain in the production of antibody-like protein products.
优选,中国仓鼠卵巢上皮细胞CHO-K1-OAL作为生产菌株在高渗透压、高铵离子、高乳酸环境下生产抗体类蛋白产品中的应用。Preferably, the Chinese hamster ovary epithelial cell CHO-K1-OAL is used as a production strain in the production of antibody-like protein products under the environment of high osmotic pressure, high ammonium ions, and high lactic acid.
优选,中国仓鼠卵巢上皮细胞CHO-K1-OAL作为生产菌株在≥350mOsm/Kg的渗透压、≥7.5mM的铵离子、≥2.5g/L的乳酸环境下生产抗体类蛋白产品中的应用。Preferably, the Chinese hamster ovary epithelial cell CHO-K1-OAL is used as a production strain in the production of antibody protein products under the osmotic pressure of ≥350mOsm/Kg, ammonium ions of ≥7.5mM, and lactic acid of ≥2.5g/L.
本发明中国仓鼠卵巢上皮细胞CHO-K1-OAL可以在高渗透压(大于350mOsm/Kg)、高铵离子(7.5mM)和高乳酸(2.5g/L)环境中正常生长,从而避免随着发酵过程的进行渗透压增加,铵离子、乳酸浓度增高而导致CHO细胞的死亡和活率下降,最终影响到细胞产率降低的缺陷。The Chinese hamster ovary epithelial cell CHO-K1-OAL of the present invention can grow normally in the environment of high osmotic pressure (more than 350mOsm/Kg), high ammonium ion (7.5mM) and high lactic acid (2.5g/L), so as to avoid the fermentation During the process, the osmotic pressure increases, and the concentration of ammonium ions and lactic acid increases, which leads to the death of CHO cells and the decrease of the viability, which ultimately affects the defect of reduced cell productivity.
中国仓鼠卵巢上皮细胞CHO-K1-OAL于2019年8月19日保藏于中国微生物菌种保藏管理委员会普通微生物中心(CGMCC),地址:北京市朝阳区北辰西路1号院3号,保藏编号为:CGMCC No.18322。The Chinese hamster ovary epithelial cell CHO-K1-OAL was deposited in the General Microbiology Center (CGMCC) of the China Microorganism Culture Collection on August 19, 2019. Address: No. 3, No. 1, Beichen West Road, Chaoyang District, Beijing, China, preservation number As: CGMCC No.18322.
附图说明:Description of drawings:
图1是CHO-K1S细胞在不同渗透压的生长曲线,其中300、350、400、450、500分别代表在渗透压为300、350、400、450、500mOsm/Kg;Figure 1 shows the growth curves of CHO-K1S cells at different osmotic pressures, where 300, 350, 400, 450, and 500 represent osmotic pressures of 300, 350, 400, 450, and 500 mOsm/Kg, respectively;
图2是CHO-K1S以及CHO-K1S-O-A生长曲线,其中300、350、400、450、500分别代表CHO-K1S细胞在渗透压为300、350、400、450、500mOsm/Kg的生长曲线,而400-A代表CHO-K1S-O-A细胞在渗透压为400mOsm/Kg的生长曲线;Figure 2 shows the growth curves of CHO-K1S and CHO-K1S-O-A, wherein 300, 350, 400, 450, and 500 represent the growth curves of CHO-K1S cells at osmotic pressures of 300, 350, 400, 450, and 500 mOsm/Kg, respectively. And 400-A represents the growth curve of CHO-K1S-O-A cells at an osmotic pressure of 400mOsm/Kg;
图3是CHO-K1S以及CHO-K1S-O-AL生长曲线,其中300、350、400、450、500分别代表CHO-K1S细胞在渗透压为300、350、400、450、500mOsm/Kg,培养基为无血清培养基CD02的生长曲线,而400-A-AL代表CHO-K1S-O-AL细胞在渗透压为400mOsm/Kg、培养基为高铵离子和高乳酸筛选培养基下的生长曲线;Figure 3 shows the growth curves of CHO-K1S and CHO-K1S-O-AL, wherein 300, 350, 400, 450, and 500 represent the osmotic pressure of CHO-K1S cells at 300, 350, 400, 450, and 500 mOsm/Kg, respectively. The base is the growth curve of serum-free medium CD02, while 400-A-AL represents the growth curve of CHO-K1S-O-AL cells under the osmotic pressure of 400mOsm/Kg, the medium is high ammonium ion and high lactate selection medium ;
图4是CHO-K1S以及CHO-K1S-OAL-A生长曲线,其中300、350、400、450、500分别代表CHO-K1S细胞在渗透压为300、350、400、450、500mOsm/Kg,培养基为无血清培养基CD02的生长曲线,而400AL-A代表CHO-K1S-OAL-A细胞在渗透压为400mOsm/Kg、培养基为高铵离子和高乳酸筛选培养基下的生长曲线。Figure 4 is the growth curve of CHO-K1S and CHO-K1S-OAL-A, wherein 300, 350, 400, 450, and 500 represent the osmotic pressure of CHO-K1S cells at 300, 350, 400, 450, and 500 mOsm/Kg, respectively. The base is the growth curve of serum-free medium CD02, and 400AL-A represents the growth curve of CHO-K1S-OAL-A cells under the osmotic pressure of 400 mOsm/Kg, the medium is high ammonium ion and high lactate selection medium.
具体实施方式:Detailed ways:
以下实施例是对本发明的进一步说明,而不是对本发明的限制。The following examples are further illustrations of the present invention, rather than limitations of the present invention.
实施例1:Example 1:
本发明选用的细胞株为CHO-K1细胞(ECACC 85051005)。所使用的培养基为QuaCell公司的CHO细胞化学成分限定的无血清培养基CD02。The selected cell line in the present invention is CHO-K1 cell (ECACC 85051005). The medium used was the CHO cell chemically defined serum-free medium CD02 from QuaCell Company.
一、细胞悬浮驯化1. Cell suspension acclimation
1、实验目的1. The purpose of the experiment
将CHO-K1(Lot:16H036)贴壁细胞驯化成悬浮细胞。CHO-K1 (Lot: 16H036) adherent cells were adapted to suspension cells.
2、实验主要材料2. The main materials of the experiment
DMEM/F12=1:1培养基(Gibco/C1133050013T)、血清(ExCell Bio/11G355)、L-谷氨酰胺(源培生物)、CD02培养基(Quacell/36A01)、T75方瓶(BIOFIL/180624-104B)、T75方瓶(BIOFIL/180508-104)、125ml摇瓶(Corning/25818010)、500ml摇瓶(Corning/11818004)、冻存管(Corning/23618076)、5ml移液管(Corning/20118020)、25ml移液管(Corning/17218010)、50ml离心管(Corning/31518601)DMEM/F12=1:1 medium (Gibco/C1133050013T), serum (ExCell Bio/11G355), L-glutamine (Original Bio), CD02 medium (Quacell/36A01), T75 square bottle (BIOFIL/180624) -104B), T75 square bottle (BIOFIL/180508-104), 125ml shaker bottle (Corning/25818010), 500ml shaker bottle (Corning/11818004), cryopreservation tube (Corning/23618076), 5ml pipette (Corning/20118020) ), 25ml pipette (Corning/17218010), 50ml centrifuge tube (Corning/31518601)
3、实验流程3. Experimental process
(1)、细胞扩增、保存(1), cell expansion, preservation
基础培养基溶液配制:DMEM/F12培养基(DMEM/F12=1:1)+10%FBS+2mM Gln细胞复苏、扩增并保存:复苏CHO-K1(Lot:16H036)细胞,用上述基础培养基溶液传代扩增培养,当细胞总数达到一定数量后,对细胞进行冻存,总共冻存8支细胞。细胞命名为CHO-K1。Basal medium solution preparation: DMEM/F12 medium (DMEM/F12=1:1)+10% FBS+2mM Gln cell recovery, expansion and preservation: recovery of CHO-K1 (Lot: 16H036) cells, using the above basal culture The base solution was subcultured and expanded, and when the total number of cells reached a certain number, the cells were cryopreserved, and a total of 8 cells were cryopreserved. Cells were named CHO-K1.
(2)、细胞悬浮驯化(2), cell suspension acclimation
a、细胞悬浮驯化培养基溶液主要成分为DMEM/F12培养基、FBS、CD02培养基、2mMGln,根据实验方案配制不同血清浓度比的细胞悬浮驯化培养基。a. The main components of the cell suspension acclimation medium solution are DMEM/F12 medium, FBS, CD02 medium, and 2mM Gln. The cell suspension acclimation medium with different serum concentration ratios was prepared according to the experimental plan.
b、复苏上述冻存的CHO-K1细胞1支,用T75方瓶做细胞传代培养。当细胞汇合度达80%后做传代处理,弃上清、消化离心重悬,取一定的重悬细胞液加入细胞悬浮驯化培养基中进行培养(每次传代培养基血清浓度比例不同),显微镜观察细胞长在形态,通过多次传代培养,让细胞逐渐悬浮(会有少量贴壁细胞)。b. Resuscitate 1 branch of the above-mentioned cryopreserved CHO-K1 cells, and use a T75 square flask for cell subculture. When the cell confluence reaches 80%, the subculture is carried out. The supernatant is discarded, digested, centrifuged and resuspended. A certain amount of the resuspended cell solution is added to the cell suspension acclimation medium for culture (the serum concentration ratio of each subculture medium is different). Observe the morphology of the cells, and gradually suspend the cells through multiple subcultures (there will be a small amount of adherent cells).
c、悬浮细胞扩增培养:将悬浮驯化后的细胞转移至125ml摇瓶中,加入新鲜CD02培养基(4mMGln)进行连续传代培养。传代细胞密度约3×105cells/ml,体积30ml。观察细胞在摇瓶中生长状态、检测细胞密度及活率等。c. Suspension cell expansion culture: transfer the acclimated cells to a 125ml shake flask, and add fresh CD02 medium (4mM Gln) for continuous subculture. The density of passaged cells is about 3×10 5 cells/ml, and the volume is 30ml. Observe the growth state of the cells in the shake flask, and detect the cell density and viability.
(3)、悬浮细胞保存(3), suspension cell preservation
取上述扩增培养液适量,离心,弃上清,用细胞冻存液(92%CD02+8%DMSO)重悬,按细胞密度1×107cells/ml,每支1ml进行分装,共分装10支冻存管,用程序降温盒放到-80℃冰箱中,24h后转移至液氮中,由此得到悬浮驯化后的细胞。Take an appropriate amount of the above-mentioned amplification medium, centrifuge, discard the supernatant, resuspend with cell freezing medium (92% CD02 + 8% DMSO), and divide it into 1 ml at a cell density of 1 × 10 7 cells/ml.
4、实验结果:4. Experimental results:
实验结论:悬浮驯化后的细胞在摇瓶中传代两次后能正常生长,最高生长密度可达2.98×106cells/ml,活率97.67%,细胞悬浮驯化成功。Experimental conclusion: The cells after suspension acclimation can grow normally after being passaged twice in the shaker flask, the highest growth density can reach 2.98×10 6 cells/ml, the viability rate is 97.67%, and the cells are acclimated successfully in suspension.
二、细胞单克隆筛选2. Cell monoclonal screening
1、实验目的1. The purpose of the experiment
从步骤一的悬浮驯化后的细胞中挑选出一株稳定的单克隆细胞株以用于后续的驯化实验。A stable monoclonal cell line was selected from the suspension acclimated cells in step 1 for subsequent acclimation experiments.
2、主要实验材料2. Main experimental materials
单克隆培养基(SIGMA/SLBX8261)、CD02培养基(Quacell/36A01)、L-谷氨酰胺(源培生物)、125ml摇瓶(Corning/25818010)、500ml摇瓶(Corning/11818004)、冻存管(Corning/23618076)、5ml移液管(Corning/20118020)、25ml移液管(Corning/17218010)、50ml离心管(Corning/31518601)、96孔板(Corning/26018036)。Monoclonal medium (SIGMA/SLBX8261), CD02 medium (Quacell/36A01), L-glutamine (Original Biology), 125ml shake flask (Corning/25818010), 500ml shake flask (Corning/11818004), cryopreservation Tube (Corning/23618076), 5ml pipette (Corning/20118020), 25ml pipette (Corning/17218010), 50ml centrifuge tube (Corning/31518601), 96-well plate (Corning/26018036).
3、实验流程及结果3. Experimental procedure and results
a、细胞复苏、传代:复苏一支步骤一的悬浮驯化后的细胞(序号为01),用CD02培养基(4mMGln)进行培养,当细胞密度达到1×106cells/ml后进行传代培养,让细胞维持良好的生长状态(细胞活率保持在95%以上)。a. Cell recovery and passage: Resuscitate a suspension-acclimated cell (serial number 01) in step 1, culture it in CD02 medium (4mM Gln), and perform subculture when the cell density reaches 1×10 6 cells/ml. Keep the cells in a good growth state (cell viability above 95%).
b、细胞铺板(96孔板):选择处于对数生长期的细胞100μl,经有限稀释后进行单克隆铺板,理论铺板密度为0.2cells/孔,加入单克隆培养基(4mMGln)200μl。一共铺板10个96孔板。b. Cell plating (96-well plate): Select 100 μl of cells in the logarithmic growth phase, perform monoclonal plating after limiting dilution, the theoretical plating density is 0.2 cells/well, and add 200 μl of monoclonal medium (4mMGln). A total of 10 96-well plates were plated.
c、单克隆细胞孔观察:铺板完成后需要将96孔板放入培养箱中静置3h,利用solentim细胞成像仪看板,找到单克隆细胞孔。单克隆细胞孔统计结果如下:c. Observation of monoclonal cell wells: After the plating is completed, the 96-well plate needs to be placed in an incubator for 3 hours, and the monoclonal cell wells are found by using a solentim cell imager to view the plate. The statistical results of monoclonal cell wells are as follows:
①:A02,A11,B05,C07,D10,F07,F09,H07①:A02,A11,B05,C07,D10,F07,F09,H07
②:A05,B11,C03,D09,F05,G02②:A05,B11,C03,D09,F05,G02
③:B03,B08,C11,D02,F06,G11,H02,H05,H11③:B03,B08,C11,D02,F06,G11,H02,H05,H11
④:C04,C06,D01,D04,E04,F02,F06④:C04,C06,D01,D04,E04,F02,F06
⑤:A02,A05,C06,C09,D06,E04,E11,H01,H11⑤:A02,A05,C06,C09,D06,E04,E11,H01,H11
⑥:C01,C05,C09,D05,E04,E08,F11,G04,H11⑥:C01,C05,C09,D05,E04,E08,F11,G04,H11
⑦:A11,A12,B09,B11,E08,F03,H07,H09⑦:A11,A12,B09,B11,E08,F03,H07,H09
⑧:A02,B05,C08,D11,D09,E11,F08,H03,H08⑧:A02,B05,C08,D11,D09,E11,F08,H03,H08
⑨:B04,C08,C11,D02,D08,E04,E11,G03⑨:B04,C08,C11,D02,D08,E04,E11,G03
⑩:A01,C02,E11,F05,F08,H03⑩:A01,C02,E11,F05,F08,H03
d、挑选优质的单克隆细胞孔:当单克隆细胞长到96孔孔内1/4面积时对其进行取样,根据细胞形态和密度选择续保生长较好的单克隆细胞孔。结果如下:d. Select high-quality monoclonal cell wells: When the monoclonal cells grow to 1/4 of the area of the 96-well wells, they will be sampled, and the monoclonal cell wells with better growth will be selected according to the cell shape and density. The result is as follows:
①:C07,D10,F07,F09,H07①: C07, D10, F07, F09, H07
②:F05②: F05
③:F06③: F06
⑤:C06,E04⑤: C06, E04
⑥:C01,C05,C09,D05,E04,E08,F11,G04,H11⑥: C01, C05, C09, D05, E04, E08, F11, G04, H11
e、单克隆细胞扩增:将上述选择的单克隆细胞孔内细胞进行吹散打匀后,放入96深孔板继续培养,加入1ml/孔的CD02培养基(4mMGln);根据细胞生长形态、活率及密度挑选了其中5株单克隆细胞株6-G04、6-F11、6-E04、6-C01、6-C09进行后续培养。e. Monoclonal cell expansion: after the cells in the above-selected monoclonal cell wells are blown, scattered and homogenized, placed in a 96 deep-well plate to continue culturing, and 1 ml/well of CD02 medium (4mM Gln) is added; According to the viability and density, 5 monoclonal cell lines, 6-G04, 6-F11, 6-E04, 6-C01, and 6-C09, were selected for subsequent culture.
f、单克隆细胞稳定传代并保存:将上述5株细胞用CD02培养基(4mMGln)以0.3×106cells/ml的传代密度进行扩增培养,传代培养3代后进行细胞冻存,每株细胞株冻存8支细胞。根据细胞生长形态、活率及密度挑选了6-G04进行后续加压驯化。f. Stable passage and preservation of monoclonal cells: the above 5 strains of cells were expanded and cultured in CD02 medium (4mM Gln) at a passage density of 0.3×10 6 cells/ml, and the cells were cryopreserved after 3 passages of passage. The cell line cryopreserved 8 cells. 6-G04 was selected for subsequent pressurized acclimation according to cell growth morphology, viability and density.
实验结论:从悬浮细胞中共挑选出5株稳定的单克隆细胞株,最终选择了6-G04这个细胞株用于后续的驯化实验,将6-G04细胞株命名为CHO-K1S细胞。Experimental conclusion: A total of 5 stable monoclonal cell lines were selected from the suspension cells, and the 6-G04 cell line was finally selected for the subsequent domestication experiments, and the 6-G04 cell line was named CHO-K1S cell.
三、高渗透压驯化3. High osmotic pressure domestication
在渗透压为300,350,400,450和500mOsm/Kg的CD02培养基(在CD02培养基中加入不同浓度的NaCl,制备成不同渗透压的CD02培养基)中分别接种CHO-K1S细胞,接种密度为0.3×106cells/ml,共30ml,于200rpm,37摄氏度,5%二氧化碳细胞培养箱中培养,每天测定细胞密度和活率,并绘制生长曲线。CHO-K1S cells were inoculated in CD02 medium with osmotic pressures of 300, 350, 400, 450 and 500 mOsm/Kg (different concentrations of NaCl were added to CD02 medium to prepare CD02 medium with different osmotic pressures), respectively. The density is 0.3×10 6 cells/ml, a total of 30 ml, cultured in a cell incubator at 200 rpm, 37 degrees Celsius, 5% carbon dioxide, and the cell density and viability are measured every day, and the growth curve is drawn.
其生长曲线如表1和图1所示:Its growth curve is shown in Table 1 and Figure 1:
表1Table 1
从上述实验中的结果分析(表1),将CHO-K1S细胞在第三天进行传代(细胞密度在2.0x 106cells/ml),共计传代10次(传代培养初始密度(0.3-0.5)E+06,传代时的密度是(1.5-2.0)E+06,一般是生长2-3天。下同),绘制第十代细胞在400mOsm/Kg CD02培养基中的生长曲线(表2和图2),由此获得400mOsm/Kg渗透压驯化后的细胞,命名为CHO-K1S-O-A细胞(表2和图2中的400-A)。From the analysis of the results in the above experiments (Table 1), the CHO-K1S cells were passaged on the third day (cell density at 2.0 x 10 6 cells/ml) for a total of 10 passages (the initial density of subculture (0.3-0.5) E+06, the density at passage is (1.5-2.0) E+06, generally grow for 2-3 days. The same below), draw the growth curve of the tenth passage cells in 400mOsm/Kg CD02 medium (Table 2 and Figure 2), thereby obtaining 400 mOsm/Kg osmotic-acclimated cells, named CHO-K1S-OA cells (400-A in Table 2 and Figure 2).
表2Table 2
经过400mOsm/Kg渗透压驯化后的CHO-K1S-O-A细胞,其生长曲线和在正常培养基(300mOsm/Kg)中的几乎吻合,而细胞初次在400mOsm/Kg渗透压下培养时其生长曲线和在正常培养基中的差异较大。The growth curve of CHO-K1S-O-A cells after acclimation at 400mOsm/Kg osmotic pressure was almost consistent with that in normal medium (300mOsm/Kg), while the growth curve of CHO-K1S-O-A cells when cultured at 400mOsm/Kg osmotic pressure for the first time was similar to The difference is larger in normal medium.
四、高渗透压高乳酸高铵离子驯化:4. High osmotic pressure, high lactic acid and high ammonium ion domestication:
以驯化成功的CHO-K1S-O-A细胞为宿主细胞,进行第二轮的适应高铵离子(7.5mM)以及高乳酸(2.5g/L)的培养环境驯化和筛选。Taking the successfully acclimated CHO-K1S-O-A cells as host cells, the second round of adaptation and selection to the culture environment with high ammonium ions (7.5mM) and high lactate (2.5g/L) was carried out.
在无血清培养基CD02添加氯化钠、氯化铵和乳酸,使得铵离子最终浓度为7.5mM,乳酸为2.5g/L,渗透压为400mOsm/Kg,由此得到高铵离子和高乳酸筛选培养基。Sodium chloride, ammonium chloride and lactic acid were added to the serum-free medium CD02, so that the final concentration of ammonium ions was 7.5 mM, the lactic acid was 2.5 g/L, and the osmotic pressure was 400 mOsm/Kg, thereby obtaining high ammonium ions and high lactic acid screening. culture medium.
首先进行的是确定CHO-K1S-O-A细胞在高铵离子和高乳酸筛选培养基中的生长情况,将CHO-K1S-O-A细胞(表3和图3中的400-A-AL)接种到高铵离子和高乳酸筛选培养基中,在渗透压为400mOsm/Kg下培养,记录其生长情况,具体见表3和图3。The first step was to determine the growth of CHO-K1S-O-A cells in high ammonium ion and high lactate selection medium, CHO-K1S-O-A cells (400-A-AL in Table 3 and Figure 3) were inoculated on high In the ammonium ion and high lactate selection medium, cultured at an osmotic pressure of 400 mOsm/Kg, and recorded its growth, see Table 3 and Figure 3 for details.
表3table 3
将CHO-K1S-O-A细胞接种到高铵离子和高乳酸筛选培养基中,在渗透压为400mOsm/Kg下培养,同样在第三天进行传代培养,共传代10次,以此稳定传代了10次的细胞作为宿主细胞,由此得到CHO-K1S-OAL-A细胞,再次将CHO-K1S-OAL-A细胞(表4和图4中的400AL-A)接种到高铵离子和高乳酸筛选培养基中,在渗透压为400mOsm/Kg下培养,记录其生长情况,具体见表4和图4。The CHO-K1S-O-A cells were inoculated into high ammonium ion and high lactic acid selection medium, cultured at an osmotic pressure of 400mOsm/Kg, and also subcultured on the third day for a total of 10 passages, thus stably passaged 10 times. CHO-K1S-OAL-A cells were obtained from the second cells as host cells, and CHO-K1S-OAL-A cells (400AL-A in Table 4 and Figure 4) were again inoculated into high ammonium ion and high lactate selection In the medium, cultured at an osmotic pressure of 400 mOsm/Kg, and recorded its growth, as shown in Table 4 and Figure 4 for details.
表4Table 4
从表4和图4可以看出,经过驯化后的CHO-K1S-OAL-A细胞,其生长曲线和正常培养基(300mOsm/Kg,未添加氯化铵和乳酸)中的类似,细胞密度在不加补料的情况下达到6.3x106cells/ml,且在D8,D9时,细胞密度都要高于正常培养基(300mOsm/Kg)中的细胞,将此细胞命名为中国仓鼠卵巢上皮细胞CHO-K1-OAL。It can be seen from Table 4 and Figure 4 that the growth curve of the acclimated CHO-K1S-OAL-A cells is similar to that in the normal medium (300mOsm/Kg, without the addition of ammonium chloride and lactic acid), and the cell density is Without feeding, it reached 6.3x10 6 cells/ml, and at D8 and D9, the cell density was higher than that in normal medium (300mOsm/Kg), and the cells were named as Chinese hamster ovary epithelial cells CHO-K1-OAL.
由此可见,本发明在已有的CHO-K1细胞群体中进行筛选,获得了可以在高渗透压(大于350mOsm/Kg)、高铵离子(7.5mM)和高乳酸(2.5g/L)环境中正常生长的的中国仓鼠卵巢上皮细胞CHO-K1-OAL。该中国仓鼠卵巢上皮细胞CHO-K1-OAL于2019年8月19日保藏于中国微生物菌种保藏管理委员会普通微生物中心(CGMCC),地址:北京市朝阳区北辰西路1号院3号,保藏编号为:CGMCC No.18322。It can be seen that the present invention performs screening in the existing CHO-K1 cell population, and obtains a high osmotic pressure (greater than 350mOsm/Kg), high ammonium ion (7.5mM) and high lactic acid (2.5g/L) environment Normal growing Chinese hamster ovary epithelial cells CHO-K1-OAL. The Chinese hamster ovary epithelial cell CHO-K1-OAL was deposited on August 19, 2019 in the General Microbiology Center (CGMCC) of the China Microorganism Culture Collection and Management Committee, address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing The serial number is: CGMCC No.18322.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911149208.9A CN111019881B (en) | 2019-11-21 | 2019-11-21 | A cell adapted to a high osmotic pressure, high ammonium ion, high lactic acid growth environment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911149208.9A CN111019881B (en) | 2019-11-21 | 2019-11-21 | A cell adapted to a high osmotic pressure, high ammonium ion, high lactic acid growth environment |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111019881A CN111019881A (en) | 2020-04-17 |
CN111019881B true CN111019881B (en) | 2020-10-09 |
Family
ID=70206248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911149208.9A Active CN111019881B (en) | 2019-11-21 | 2019-11-21 | A cell adapted to a high osmotic pressure, high ammonium ion, high lactic acid growth environment |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111019881B (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010003622A (en) * | 2007-10-12 | 2010-04-14 | Hoffmann La Roche | Protein expression from multiple nucleic acids. |
KR100999040B1 (en) * | 2008-05-28 | 2010-12-09 | 한국과학기술원 | Method of enhancing production of human interferon beta monomer, a target protein, using a transformed cell line incorporating a vector expressing human interferon beta |
CN105311630B (en) * | 2014-06-20 | 2019-07-09 | 普莱柯生物工程股份有限公司 | A kind of mammalian cell suspension culture prepares the method and application of vaccine |
CN104862280A (en) * | 2015-05-29 | 2015-08-26 | 上海大学 | Method for screening target protein CHO expressing cell strain applied to large-scale suspension culture |
CN105838664B (en) * | 2016-04-20 | 2020-08-04 | 深圳未名新鹏生物医药有限公司 | Method for producing recombinant human thrombopoietin by cell suspension culture |
CN109321519B (en) * | 2018-09-11 | 2021-01-08 | 上海奥浦迈生物科技股份有限公司 | CHO-K1 suspension domestication culture medium and domestication method |
-
2019
- 2019-11-21 CN CN201911149208.9A patent/CN111019881B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN111019881A (en) | 2020-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103205396B (en) | Suspension acclimatization and serum-free acclimatization method for HEK (human embryonic kidney)-293T cells | |
CN103013913A (en) | Method for culturing human amniotic mesenchymal stem cells by enzyme digestion and EGF (epidermal growth factor) | |
CN107385517A (en) | The construction method of mesenchyma stem cell | |
KR20100091192A (en) | Methods for co-culturing cord blood derived cells with menstrual stem cells | |
CN103789263A (en) | Construction method of bastard halibut brain cell system | |
CN106011052B (en) | A method for preparing high-purity menstrual blood-derived stem cells | |
CN103031270A (en) | Efficient amplifying and culturing method for biliary epithelial cells | |
CN103484424B (en) | Single cell cloning method for obtaining goat mammary epithetical cells | |
CN111019881B (en) | A cell adapted to a high osmotic pressure, high ammonium ion, high lactic acid growth environment | |
CN112941011B (en) | A kind of saddle grouper head kidney cell line and its construction method and application | |
CN116536251B (en) | Feeder layer-free chemically-induced pluripotent stem cell monoclonal strain establishment method | |
CN110438066B (en) | Mammalian cell line 293C18P capable of being stably passaged and capable of being cultured in suspension, and preparation method and application thereof | |
CN101892191A (en) | Method for Inducing Mouse Embryonic Stem Cells to Differentiate into Nerve Cells | |
CN110358724B (en) | Isolation and culture method of primary bronchial epithelial cells for COPD patients | |
CN104745529B (en) | Leptin is divided into purposes and its application in hematopoietic stem/progenitor in inducing embryo stem cell | |
CN110305844B (en) | Crucian spinal cord tissue cell line and application thereof | |
CN108034634B (en) | Method for separating endometrial mesenchymal stem cells from menstrual blood | |
WO2024051022A1 (en) | Hek293 monoclonal cell population culturing method | |
CN114774363B (en) | A method for obtaining tumor stem cells | |
CN110499279A (en) | A method for inducing human urine-derived stem cells to differentiate into liver cells | |
CN115029305A (en) | Separation and identification method for pig FAPs (FAPs) cells and application of FAPs cells | |
CN110760475A (en) | A method for separating and culturing chicken muscle satellite cells | |
CN109517800B (en) | Reconstructed ST cell for reinforcing endogenous synthesis of cholesterol and construction method and application thereof | |
CN105441382A (en) | Sorting method of liver cells differentiated from embryonic stem cells | |
CN111893088A (en) | A method for in vitro isolation and culture of Mongolian horse testicular spermatogonial stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |